Am J Gastroenterol

1. ISHIHARA R, Takahashi H, Abe S, Yoshio T, et al
   Long-term Outcomes After Endoscopic Resection for pMM/SM1 Esophageal Cancer: A Multicenter Prospective Cohort Study.
   Am J Gastroenterol. 2026 Sep 18. doi: 10.14309/ajg.0000000000004209.
   

   >> Share

   
   

   
   Ann Thorac Surg

2. HONG J, Wang P, Liu X, Liu S, et al
   Metastatic Lymph Node Station Count and Risk of First Distant Metastasis After Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma.
   Ann Thorac Surg. 2026 Sep 15:S0003-4975(26)00911.
   

   >> Share

   
   

   
   BMC Cancer

3. RADHAKRISHNA G, Jones CM, Bleaney CW, Blackshaw J, et al
   Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS study.
   BMC Cancer. 2026;26:1101.
   

   >> Share

   
   
4. YAO Y, Huang L, Xia R, Yuan Y, et al
   CXCR6 and its correlated G protein-coupled receptors and PI3K-AKT pathways were associated with the progression of thyroid cancer.
   BMC Cancer. 2026 Jul 10. doi: 10.1186/s12885-026-16513.
   

   >> Share

   
   

   
   Br J Cancer

5. GROTHEY B, Kramer M, Montalbano M, Lyu SI, et al
   Proteomic characterization of SMARCA-deficient esophageal adenocarcinoma reveals complement evasion and DNA repair-associated prognostic subgroups.
   Br J Cancer. 2026;135:1119-1130.
   

   >> Share

   
   

   
   Head Neck

6. LINDEGAARD AM, Haakansson K, Andersen M, Bernsdorf M, et al
   Pattern of Failure in Nasopharyngeal Carcinoma After Radiotherapy in a Low-Incidence Population: A DAHANCA Study.
   Head Neck. 2026 Sep 16. doi: 10.1002/hed.70460.
   

   >> Share

   
   
7. LAI CC, Chen JY, Lin JJ, Hsiao MY, et al
   Association Between Temporalis Muscle Thickness and Risk of Disability and Mortality in Patients With Oral Cancer.
   Head Neck. 2026 Sep 15. doi: 10.1002/hed.70477.
   

   >> Share

   
   

   
   Int J Cancer

8. SHI X, Xu W, Wu Y, Yang Y, et al
   Heterogeneity in Postoperative Survival Benefit Associated With Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma: A Causal Survival Forest Analysis.
   Int J Cancer. 2026 Sep 15. doi: 10.1002/ijc.70729.
   

   >> Share

   
   

   
   J Clin Endocrinol Metab

9. PITT S, Haymart MR
   Approach to the Patient with Low-Risk Thyroid Cancer.
   J Clin Endocrinol Metab. 2026 Jun 24:dgag243. doi: 10.1210.
   

   >> Share

   
   
10. GRAF KE, Adam P, Megerle F, Machlah YM, et al
    Outcome Of First-Line Chemotherapy For Anaplastic Thyroid Cancer - A Multicenter Registry Analysis.
    J Clin Endocrinol Metab. 2026 Apr 21:dgag177. doi: 10.1210.
    

    >> Share

    
    
11. LARIOS F, Borras-Osorio M, Wu Y, Claros AG, et al
    Artificial Intelligence-Enabled Analysis of Radiology Reports: Epidemiology and Outcomes of Incidental Thyroid Findings.
    J Clin Endocrinol Metab. 2026 Apr 27:dgag186. doi: 10.1210.
    

    >> Share

    
    

    
    J Clin Oncol

12. CHEN GL, Guo Y, Liu X, Yang Y, et al
    Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.
    J Clin Oncol. 2026;44:2614-2624.
    

    >> Share

    
    
13. OKANO S, Tahara M, Tsukahara K, Otsuka T, et al
    Darolutamide Alone and in Combination With Goserelin in Androgen Receptor-Positive Salivary Gland Carcinoma: Results From the Phase II DISCOVARY Trial.
    J Clin Oncol. 2026;44:2602-2613.
    

    >> Share

    
    

    
    Laryngoscope

14. BISKADUROS A, Islam A, Odedo C, Kutler RB, et al
    Recipient and Donor Factors Impacting Head and Neck Squamous Cell Carcinoma Risk After Transplant.
    Laryngoscope. 2026 Sep 15. doi: 10.1002/lary.70914.
    

    >> Share

    
    
15. DUAN X, Lin Z
    Clinical Relevance and Regulatory Mechanisms of LINC01521 in Papillary Thyroid Carcinoma.
    Laryngoscope. 2026 Sep 16. doi: 10.1002/lary.70905.
    

    >> Share

    
    
16. PORTO-GUTIERREZ F, Kacin A, Campbell B, Montanez-Azcarate V, et al
    Lymphovascular Invasion Predicts Survival in Laryngeal Cancer: A National Database Analysis.
    Laryngoscope. 2026 Sep 18. doi: 10.1002/lary.70895.
    

    >> Share

    
    

    
    Oral Oncol

17. CHEN F, Yang X
    Letter to the Editor: Exercise prehabilitation in head and neck cancer patients proposed for definitive chemoradiotherapy: The FIT4TREAT randomized controlled trial.
    Oral Oncol. 2026;182:108144.
    

    >> Share

    
    

    
    Otolaryngol Head Neck Surg

18. ERTURK B, Duzlu M, Erpolat OP, Keser I, et al
    Prophylactic Home-Based Exercises During Radiotherapy in Head and Neck Cancer: A Randomized Controlled Trial.
    Otolaryngol Head Neck Surg. 2026 Sep 13. doi: 10.1002/ohn.70442.
    

    >> Share

    
    

    
    PLoS One

19. DEFTEREOS I, Yeung J, Kiss N, Carter V, et al
    "I had your number on speed dial:" A qualitative study of patient experiences of dietetics care and managing nutrition during curative treatment of upper gastrointestinal cancer.
    PLoS One. 2026;21:e0357580.
    

    >> Share

    
    
20. BEYEN TK, Seife E, Deressa BT, Taye G, et al
    Spatial clustering of esophageal cancer in central Oromia, Ethiopia: A spatial autocorrelation and scan statistics analysis.
    PLoS One. 2026;21:e0357042.
    

    >> Share

    
    
21. FENG Y, Zhang Y, Ou H, Tang Q, et al
    PANoptosis-based HNSCPAN-index predicts prognosis and reveals DSCAM as a therapeutic target in head and neck squamous cell carcinoma.
    PLoS One. 2026;21:e0344957.
    

    >> Share

    
    

    
    Radiology

22. LI J, Xiao L, Qu X, Du L, et al
    Bridging the Generalist-Subspecialist Gap with GPT-5-Thinking: Dual-Center Evaluation in Orbital and Head-and-Neck Tumor MRI Reports.
    Radiology. 2026;320:e253579.
    

    >> Share

    
    

    
    Radiother Oncol

23. CANTERS R, Badiu V, Reijtenbagh D, Kneepkens E, et al
    Corrigendum to "Temporal heart dose variations during IMPT for esophageal cancer and the impact of an adaptation protocol" [Radiother. Oncol. 223 (2026) 111717].
    Radiother Oncol. 2026;224:111773.
    

    >> Share

    
    
24. HUANG R, Lou J, Li C, Xu Z, et al
    Risk and prognostic survival analysis of radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma: intensity-modulated radiotherapy and two-dimensional radiotherapy.
    Radiother Oncol. 2026 Sep 13:111776. doi: 10.1016/j.radonc.2026.111776.
    

    >> Share

    
    

    
    Surgery

25. LIU C, Liu L, Wu J, Yang F, et al
    Extent of lymphadenectomy and prognosis in N1b papillary thyroid cancer: A multicenter retrospective cohort study.
    Surgery. 2026;198:110442.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share